{"pmid":32463545,"title":"Obesity and COVID-19: an Italian snapshot.","text":["Obesity and COVID-19: an Italian snapshot.","OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients.","Obesity (Silver Spring)","Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto","32463545"],"abstract":["OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients."],"journal":"Obesity (Silver Spring)","authors":["Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463545","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/oby.22918","keywords":["covid-19","sars-cov-2","obesity"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668079521204535298,"score":9.490897,"similar":[{"pmid":32271993,"title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","text":["High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals.","Obesity (Silver Spring)","Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce","32271993"],"abstract":["OBJECTIVE: The Covid-19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has not been fully documented. METHODS: In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS-CoV-2, in a single French center. RESULTS: Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p<0.01, Chi square test for trend), and it was greatest in patients with BMI >35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p<0.05) and BMI (p<0.05), independent of age, diabetes, and hypertension. The odds ratio for IMV in patients with BMI >35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63-33.14; p=0.02) CONCLUSION: The present study showed a high frequency of obesity among patients admitted in intensive care for SARS-CoV-2. Disease severity increased with BMI. Obesity is a risk factor for SARS-CoV-2 severity requiring increased attention to preventive measures in susceptible individuals."],"journal":"Obesity (Silver Spring)","authors":["Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271993","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/oby.22831","keywords":["covid-19","sras-cov-2","body mass index","intensive care","mechanical ventilation","obesity"],"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666138491829878786,"score":337.12827},{"pmid":32409502,"title":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","text":["Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.","Diabetes Care","Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin","32409502"],"abstract":["OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment."],"journal":"Diabetes Care","authors":["Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409502","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.2337/dc20-0576","locations":["Shenzhen","China","Obese","obese","obese","obese","obese","obese","Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666897319116668929,"score":303.74667},{"pmid":32352637,"title":"Association of Obesity with Disease Severity among Patients with COVID-19.","text":["Association of Obesity with Disease Severity among Patients with COVID-19.","OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted.","Obesity (Silver Spring)","Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios","32352637"],"abstract":["OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted."],"journal":"Obesity (Silver Spring)","authors":["Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352637","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22859","keywords":["covid-19","icu","sars-cov-2","hospitalization","intubation","obesity"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495752601600,"score":279.51834},{"pmid":32422233,"title":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","text":["Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes.","Metabolism","Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S","32422233"],"abstract":["BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes."],"journal":"Metabolism","authors":["Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422233","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.metabol.2020.154262","keywords":["bronx","covid-19","new york","sars-cov-2","coronavirus","mortality","obesity","pandemic","risk factor"],"locations":["New York","Bronx","African American","hyperlipidemia","Bronx","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667159284600799232,"score":275.8902},{"pmid":32470210,"title":"Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.","text":["Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.","OBJECTIVE: The 2019 novel coronavirus disease (COVID-19) has triggered a rapidly-expanding global pandemic in which patients exhibit a wide spectrum of disease severity. Given the high prevalence of obesity in the United States, we hypothesized that the presence of obesity may play a role in the clinical course of COVID-19 patients. METHODS: This is a retrospective review of adult patients admitted with confirmed SARS-CoV-2. Demographics, clinical characteristics, laboratory data, and clinical outcomes were abstracted. BMI (kg/m(2) ) was analyzed with regard to a composite outcome of ICU admission or death, and intubation rate. RESULTS: 770 patients were included (61% male, mean age 63.5 yrs). Obese patients were more likely to present with fever, cough and shortness of breath. Obesity was also associated with a significantly higher rate of ICU admission or death (RR = 1.58, p = 0.002) even after adjusting for age, race and troponin level. CONCLUSIONS: Obese patients had an increased risk of critical illness leading to ICU admission or death compared to normal weight individuals. This study confirms that obesity is a major risk factor for COVID-19 disease severity, significantly impacting disease presentation and critical care requirements.","Obesity (Silver Spring)","Hajifathalian, Kaveh","Kumar, Sonal","Newberry, Carolyn","Shah, Shawn","Fortune, Brett","Krisko, Tibor","Ortiz-Pujols, Shiara","Zhou, Xi Kathy","Dannenberg, Andrew J","Kumar, Rekha","Sharaiha, Reem Z","32470210"],"abstract":["OBJECTIVE: The 2019 novel coronavirus disease (COVID-19) has triggered a rapidly-expanding global pandemic in which patients exhibit a wide spectrum of disease severity. Given the high prevalence of obesity in the United States, we hypothesized that the presence of obesity may play a role in the clinical course of COVID-19 patients. METHODS: This is a retrospective review of adult patients admitted with confirmed SARS-CoV-2. Demographics, clinical characteristics, laboratory data, and clinical outcomes were abstracted. BMI (kg/m(2) ) was analyzed with regard to a composite outcome of ICU admission or death, and intubation rate. RESULTS: 770 patients were included (61% male, mean age 63.5 yrs). Obese patients were more likely to present with fever, cough and shortness of breath. Obesity was also associated with a significantly higher rate of ICU admission or death (RR = 1.58, p = 0.002) even after adjusting for age, race and troponin level. CONCLUSIONS: Obese patients had an increased risk of critical illness leading to ICU admission or death compared to normal weight individuals. This study confirms that obesity is a major risk factor for COVID-19 disease severity, significantly impacting disease presentation and critical care requirements."],"journal":"Obesity (Silver Spring)","authors":["Hajifathalian, Kaveh","Kumar, Sonal","Newberry, Carolyn","Shah, Shawn","Fortune, Brett","Krisko, Tibor","Ortiz-Pujols, Shiara","Zhou, Xi Kathy","Dannenberg, Andrew J","Kumar, Rekha","Sharaiha, Reem Z"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470210","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/oby.22923","keywords":["body mass index (bmi)","covid-19","mortality","obesity","sars-cov-2"],"locations":["United States","Obese","Obese","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668420887278256128,"score":275.24936}]}